CN101623378B - Chinese medicament for treating high blood pressure - Google Patents
Chinese medicament for treating high blood pressure Download PDFInfo
- Publication number
- CN101623378B CN101623378B CN2008100859950A CN200810085995A CN101623378B CN 101623378 B CN101623378 B CN 101623378B CN 2008100859950 A CN2008100859950 A CN 2008100859950A CN 200810085995 A CN200810085995 A CN 200810085995A CN 101623378 B CN101623378 B CN 101623378B
- Authority
- CN
- China
- Prior art keywords
- radix
- blood pressure
- high blood
- medicine
- chinese medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses Chinese medicament powder for treating high blood pressure, which is prepared by the following steps: taking raw materials, namely American ginseng, fresh rehmannia, danshen root, eucommia bark, Chinese taxilus twig, cassia seed, fresh achyranthes and gambir plant; sun-drying and grinding the raw materials for preparation in proportions; and then preparing powder after aging and sterilization. The Chinese medicament for treating the high blood pressure has the characteristics of unique formula, remarkable treatment effect, no toxic and side effect, no dependence of patients on the Chinese medicament and the like.
Description
Technical field:
The present invention relates to the hypertensive Chinese medicine of a kind of treatment.
Background technology:
Hypertension is the common frdquently encountered disease of serious harm human health, and such disease and complication thereof seize China hundreds of thousands people life every year, and this number is ascendant trend year by year, and the treatment of hypertension and complication thereof is a difficult medical problem always.At present mainly adopt Western medicine and Chinese medicine dual mode to treat to the treatment of this class disease both at home and abroad, Western medicine all contains the ingredient of diuretic, diuresis and blood vessel dilating basically, it is many that medicine is eaten, vasodilation, water conservancy has been descended, and the viscosity of the blood of taking medicine for a long time also can increase gradually, in case people's drug withdrawal, disease will recur again, causes the dependency of people to medicine.Though the Chinese patent medicine of some treatment hypertension is also arranged, because effect is not fairly obvious, the patient still depends on some Western medicine, as: precious chrysanthemum chiang ya wan, XINNAOKANG etc. though hypotensive effect is arranged, to recovering the body normal physiological function, are difficult to prove effective.
Summary of the invention:
The hypertensive Chinese medicine of treatment that the object of the present invention is to provide a kind of blood pressure lowering, improve cardiac and cerebral blood-supply, enhancing human body immunity, curative effect are lasting, have no side effect.
Solution of the present invention is based on mechanism understanding and the Therapeutic Principle of motherland's medical science to high blood pressure disease, filtering out from Chinese medicine can the suppressing the hyperactive liver blood pressure lowering, heat clearing and blood circulation promoting, hypertension and hyperlipemia, conducting blood to flow downwards, reinforcing both QI and YIN, blood stasis dispelling diuretic natural edible-plant Chinese medicine, according to the theory of Chinese medical science prescription, make its performance mass action, regulate nervus centralis, blood vessel dilating, coronary blood flow increasing, regulate triglyceride and cholesterol metabolism, can increase immunity of organism again, thereby bring high blood pressure down, blood fat reducing, improve heart and brain kidney blood supply situation.
Medicine of the present invention is to be made by following weight proportion material component:
Radix Panacis Quinquefolii 1-5 Radix Rehmanniae 2-8 Radix Salviae Miltiorrhizae 3-8 Cortex Eucommiae 1-5
Herba Taxilli 1-5 Semen Cassiae 2-8 gives birth to Radix Achyranthis Bidentatae 15-40 Ramulus Uncariae Cum Uncis 10-30.
The material component preferred weight ratio range of preparation medicine of the present invention is:
Radix Panacis Quinquefolii 1-3 Radix Rehmanniae 5-7 Radix Salviae Miltiorrhizae 3-5 Cortex Eucommiae 2-4
Herba Taxilli 2-4 Semen Cassiae 2-5 gives birth to Radix Achyranthis Bidentatae 25-35 Ramulus Uncariae Cum Uncis 15-25.
After above-mentioned each component raw material is dried levigate uniform mixing, make powder.
Clinical drug of the present invention uses the result to show that its advantage is: the medicine components that the present invention selects for use belongs to natural edible-plant Chinese medicine and is raw material, comply with relevant regulations, utilize the Chinese medicine comprehensive function treatment hypertension of respectively distinguishing the flavor of without any side effects, good effect, need not to take for a long time, easy to make.
For showing the therapeutic effect of Chinese medicine of the present invention to hypertension, the present invention carries out clinical observation through 100 routine patients for test group, and to select medical history, the state of an illness, 100 suitable routine patients of age to adopt former Therapeutic Method simultaneously be matched group.In the 100 routine test group, man 65 people, women 35 people, maximum 87 years old age, minimal ages 30 years old, after stopping other medication, take medicine of the present invention, administrated method is: oral 2-2.5 gram, three times on the one, one after each meal, one month is a course of treatment, shows by clinical trial, cure 10 examples a course of treatment, cure 30 examples two courses of treatment, cure 60 examples three courses of treatment, wherein the Zhenju Jiangya Tablet healing is taken in the high especially person's cooperation of 10 routine blood pressures, total effective rate 100%, cure rate 90% (criterion of cure is not see recurrence more than drug withdrawal later six months).Matched group is taken XINNAOKANG, distressed fixed, administrated method and the requirement of consumption by specification by former Therapeutic Method, effective percentage 100%, cure rate is relatively poor, and can not drug withdrawal, in case drug withdrawal will be repeatedly, its blood pressure contrast saw the following form before and after test group and matched group patient took medicine:
Determination data shows: after taking medicine of the present invention, patient's obvious effective rate 100%, cure rate reaches 90%, blood pressure lowering effect is obvious, patient does not have dependency to medicine, do not need to take medicine for a long time, to human body without any toxic and side effects.
The specific embodiment:
Take by weighing raw material by following parts by weight:
Radix Panacis Quinquefolii 2 Radix Rehmanniae 6 Radix Salviae Miltiorrhizaes 4 Cortexs Eucommiae 3
Herba Taxilli 3 Semen Cassiaes 3 are given birth to Radix Achyranthis Bidentatae 30 Ramulus Uncariae Cum Uncis 20.
Above-mentioned Chinese medicine is screened respectively after Ex-all dries, with health level pulverizer that it is levigate, its granularity is 160 orders, with behind the various component Chinese medicine fine powder uniform mixing, insulation is 10 minutes under 110 ℃ of temperature then, is reduced to 100 ℃ of insulations again and carries out the ripening sterilization in 5 minutes, make powder after the cooling, if when adopting loose powder bag packing, every bag of Chinese medicine weight of the present invention is 2.5 grams, and the weight of every Chinese medicine of the present invention is 0.5 gram when being made as capsule.
Claims (2)
1. hypertensive Chinese powder medicine of treatment is characterized in that it is made up of following portions by weight proportion raw material medicine:
Radix Panacis Quinquefolii 1-5 Radix Rehmanniae 2-8 Radix Salviae Miltiorrhizae 3-8 Cortex Eucommiae 1-5
Herba Taxilli 1-5 Semen Cassiae 2-8 gives birth to Radix Achyranthis Bidentatae 15-40 Ramulus Uncariae Cum Uncis 10-30.
2. the hypertensive Chinese powder medicine of a kind of treatment according to claim 1 is characterized in that the parts by weight proportioning of described each crude drug is:
Radix Panacis Quinquefolii 1-3 Radix Rehmanniae 5-7 Radix Salviae Miltiorrhizae 3-5 Cortex Eucommiae 2-4
Herba Taxilli 2-4 Semen Cassiae 2-5 gives birth to Radix Achyranthis Bidentatae 25-35 Ramulus Uncariae Cum Uncis 15-25.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100859950A CN101623378B (en) | 2008-07-07 | 2008-07-07 | Chinese medicament for treating high blood pressure |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100859950A CN101623378B (en) | 2008-07-07 | 2008-07-07 | Chinese medicament for treating high blood pressure |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101623378A CN101623378A (en) | 2010-01-13 |
| CN101623378B true CN101623378B (en) | 2011-03-30 |
Family
ID=41519473
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008100859950A Expired - Fee Related CN101623378B (en) | 2008-07-07 | 2008-07-07 | Chinese medicament for treating high blood pressure |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101623378B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110251597A (en) * | 2019-07-18 | 2019-09-20 | 中国人民解放军第四军医大学 | A kind of pharmaceutical composition for treating hypertension |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1228326A (en) * | 1998-03-11 | 1999-09-15 | 廖秋 | Blood pressure lowering pill |
| CN100998754A (en) * | 2006-12-28 | 2007-07-18 | 江军锋 | Oral traditional Chinese medicine for treating vertiginous type hypertension |
-
2008
- 2008-07-07 CN CN2008100859950A patent/CN101623378B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1228326A (en) * | 1998-03-11 | 1999-09-15 | 廖秋 | Blood pressure lowering pill |
| CN100998754A (en) * | 2006-12-28 | 2007-07-18 | 江军锋 | Oral traditional Chinese medicine for treating vertiginous type hypertension |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101623378A (en) | 2010-01-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104095136B (en) | A kind of blood pressure lowering kudzu root tea | |
| CN101716242B (en) | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases | |
| CN101979020B (en) | Chinese medicinal preparation for treating high blood pressure | |
| CN101744970B (en) | Medicine used for type 2 diabetes and preparation method thereof | |
| CN101822789B (en) | Hypotensor treating essential hypertension | |
| CN101507776B (en) | Traditional Chinese medicine preparation for treating kidney deficiency, waist and knees soreness and preparation method thereof | |
| CN102258686B (en) | Chinese medicinal preparation for preventing and treating cardiovascular and cerebrovascular diseases | |
| CN101095768B (en) | Chinese traditional medicine capsule for treating primary hypertension for persons in middle and old age | |
| CN103479754B (en) | Hypotensive drug and preparation method thereof | |
| CN104922299A (en) | Traditional Chinese medicine healthcare oral liquid used for preventing and treating diabetic retinopathy | |
| CN103251796A (en) | Traditional Chinese medicine for treating insomnia | |
| CN102688361A (en) | Traditional Chinese medicinal composition for treating dysmenorrhoea and preparation thereof | |
| CN101623378B (en) | Chinese medicament for treating high blood pressure | |
| CN104324134B (en) | One kind improves microcirculatory Chinese medicine composition and preparation method thereof | |
| CN103385963B (en) | Chinese medicine preparation for treating angina pectoris caused by coronary heart disease | |
| CN102302579A (en) | Medicament for treating obesity | |
| CN102552724B (en) | Chinese medicine composite for curing hypertension | |
| CN101658566B (en) | Chinese medicinal composition for treating hypertension | |
| CN103495108A (en) | Medicine for treating chronic hypotension and preparation method for medicine | |
| CN1238016C (en) | Medicine for treating cardiovascular disease | |
| CN102652822A (en) | Traditional Chinese medicine oral liquid used for curing coronary heart disease | |
| CN102824461A (en) | Medicine for treating hypertension and preparation method thereof | |
| CN103006981A (en) | Chinese patent drug for treating cardiovascular and cerebrovascular diseases and preparation method thereof | |
| CN102100853B (en) | Traditional Chinese medicine for treating gout and preparation method thereof | |
| CN114767809A (en) | A Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases, and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110330 Termination date: 20110707 |